Global Checkpoint Inhibitors for Treating Cancer Market Research Report 2015-2025
- HEY3759313
- 89 Pages
- February 2020
- Healthcare
Checkpoint inhibitors for treating cancer is a type of drug that blocks certain proteins made by some types of immune system cells, such as T cells, and some cancer cells. These proteins help keep immune responses in check and can keep T cells from killing cancer cells. When these proteins are blocked, the “brakes” on the immune system are released and T cells are able to kill cancer cells better. Examples of checkpoint proteins found on T cells or cancer cells include PD-1/PD-L1 and CTLA-4/B7-1/B7-2.
The global Checkpoint Inhibitors for Treating Cancer market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
PD-1 inhibitors
PD-L1 inhibitors
CTLA-4 inhibitors
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
Bristol-Myers Squibb(BMS)
Merck
Roche
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Melanoma treatment
Bladder cancer treatment
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Checkpoint Inhibitors for Treating Cancer Picture
1.1.2 Specifications
Table Product Specifications of Checkpoint Inhibitors for Treating Cancer
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2011-2022 (USD Million)
1.2.1.1 PD-1 inhibitors
Table PD-1 inhibitors Overview
1.2.1.2 PD-L1 inhibitors
Table PD-L1 inhibitors Overview
1.2.1.3 CTLA-4 inhibitors
Table CTLA-4 inhibitors Overview
1.2.2 by Application
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2011-2022 (USD Million)
1.2.2.1 Melanoma treatment
Table Melanoma treatment Overview
1.2.2.2 Bladder cancer treatment
Table Bladder cancer treatment Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Checkpoint Inhibitors for Treating Cancer
2.2 Upstream
Table Cost of Checkpoint Inhibitors for Treating Cancer
Figure Manufacturing Process of Checkpoint Inhibitors for Treating Cancer
2.3 Market
2.3.1 SWOT
Figure SWOT of Checkpoint Inhibitors for Treating Cancer
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Checkpoint Inhibitors for Treating Cancer
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Checkpoint Inhibitors for Treating Cancer
3.4 Market Entry
Table Market Entry of Checkpoint Inhibitors for Treating Cancer
4 Market Segmentation by Type
4.1 Market Size
4.1.1 PD-1 inhibitors Market, 2013-2018
Figure PD-1 inhibitors Market Size and Growth, 2015-2019 (USD Million)
Figure PD-1 inhibitors Market Size and Growth, 2015-2019 (in Volume)
Table PD-1 inhibitors CAGR by Revenue and Volume, 2015-2019
4.1.2 PD-L1 inhibitors Market, 2013-2018
Figure PD-L1 inhibitors Market Size and Growth, 2015-2019 (USD Million)
Figure PD-L1 inhibitors Market Size and Growth, 2015-2019 (in Volume)
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2015-2019
4.1.3 CTLA-4 inhibitors Market, 2013-2018
Figure CTLA-4 inhibitors Market Size and Growth, 2015-2019 (USD Million)
Figure CTLA-4 inhibitors Market Size and Growth, 2015-2019 (in Volume)
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 PD-1 inhibitors Market Forecast, 2020-2025
Figure PD-1 inhibitors Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure PD-1 inhibitors Market Estimates and Forecasts, 2020-2025 (in Volume)
Table PD-1 inhibitors CAGR by Revenue and Volume, 2012-2024
4.2.2 PD-L1 inhibitors Market Forecast, 2020-2025
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure PD-L1 inhibitors Market Estimates and Forecasts, 2020-2025 (in Volume)
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2012-2024
4.2.3 CTLA-4 inhibitors Market Forecast, 2020-2025
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure CTLA-4 inhibitors Market Estimates and Forecasts, 2020-2025 (in Volume)
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Melanoma treatment Market, 2013-2018
Figure Melanoma treatment Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Melanoma treatment CAGR by Revenue and Volume, 2015-2019
5.1.2 Bladder cancer treatment Market, 2013-2018
Figure Bladder cancer treatment Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Bladder cancer treatment CAGR by Revenue and Volume, 2015-2019
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Melanoma treatment Market Forecast, 2020-2025
Figure Melanoma treatment Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Melanoma treatment Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Melanoma treatment CAGR by Revenue and Volume, 2020-2025
5.2.2 Bladder cancer treatment Market Forecast, 2020-2025
Figure Bladder cancer treatment Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Bladder cancer treatment Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Bladder cancer treatment CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Checkpoint Inhibitors for Treating Cancer Market by Vendors, 2015-2019 (in Volume)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2015-2019 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Checkpoint Inhibitors for Treating Cancer Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 Bristol-Myers Squibb(BMS)
Table Bristol-Myers Squibb(BMS) Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Merck
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Checkpoint Inhibitors for Treating Cancer
Table Products Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Type, 2011-2022 (USD Million)
Table PD-1 inhibitors Overview
Table PD-L1 inhibitors Overview
Table CTLA-4 inhibitors Overview
Table Application Segment of Checkpoint Inhibitors for Treating Cancer
Table Global Checkpoint Inhibitors for Treating Cancer Market by Application, 2011-2022 (USD Million)
Table Melanoma treatment Overview
Table Bladder cancer treatment Overview
Table Others Overview
Table Global Checkpoint Inhibitors for Treating Cancer Market by Region, 2011-2022 (USD Million)
Table Cost of Checkpoint Inhibitors for Treating Cancer
Table Market Dynamics
Table Policy of Checkpoint Inhibitors for Treating Cancer
Table GDP of Major Countries
Table Technology of Checkpoint Inhibitors for Treating Cancer
Table Market Entry of Checkpoint Inhibitors for Treating Cancer
Table PD-1 inhibitors CAGR by Revenue and Volume, 2015-2019
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2015-2019
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2015-2019
Table PD-1 inhibitors CAGR by Revenue and Volume, 2012-2024
Table PD-L1 inhibitors CAGR by Revenue and Volume, 2012-2024
Table CTLA-4 inhibitors CAGR by Revenue and Volume, 2012-2024
Table Melanoma treatment CAGR by Revenue and Volume, 2015-2019
Table Bladder cancer treatment CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Melanoma treatment CAGR by Revenue and Volume, 2020-2025
Table Bladder cancer treatment CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Checkpoint Inhibitors for Treating Cancer Market by Vendors, 2015-2019 (in Volume)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2015-2019 (USD Million)
Table Global Checkpoint Inhibitors for Treating Cancer Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table Bristol-Myers Squibb(BMS) Profile List
Table Microecological Modulator Operating Data of Bristol-Myers Squibb(BMS) (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
